Revisión
La resistencia en el tratamiento secundario del ictus isquémico, el componente genético en la respuesta a ácido acetilsalicílico y clopidogrel
Drug resistance and secondary treatment of ischaemic stroke: The genetic component of the response to acetylsalicylic acid and clopidogrel
C. Gallego-Fabregaa, J. Krupinskib,c, I. Fernandez-Cadenasa,
, en nombre de Genestroke Consortium, Consorcio Español para el Estudio Genético del Ictus
Autor para correspondencia
a Laboratorio de Genética y Farmacogenómica Neurovascular, Fundació Docència i Recerca Mútua Terrassa, Terrassa, Barcelona, España
b Servicio de Neurología, Hospital Universitari Mútua Terrassa, Terrasa, Barcelona, España
c School of Healthcare Science, Manchester Metropolitan University, Manchester, Inglaterra
Leído
6801
Vecesse ha leído el artículo
1540
Total PDF
5261
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 13 | 8 | 21 |
| 2025 11 | 37 | 23 | 60 |
| 2025 10 | 59 | 9 | 68 |
| 2025 9 | 49 | 19 | 68 |
| 2025 8 | 40 | 14 | 54 |
| 2025 7 | 49 | 6 | 55 |
| 2025 6 | 38 | 9 | 47 |
| 2025 5 | 40 | 11 | 51 |
| 2025 4 | 53 | 7 | 60 |
| 2025 3 | 45 | 4 | 49 |
| 2025 2 | 46 | 14 | 60 |
| 2025 1 | 45 | 7 | 52 |
| 2024 12 | 45 | 5 | 50 |
| 2024 11 | 38 | 4 | 42 |
| 2024 10 | 35 | 7 | 42 |
| 2024 9 | 43 | 5 | 48 |
| 2024 8 | 25 | 7 | 32 |
| 2024 7 | 51 | 4 | 55 |
| 2024 6 | 32 | 4 | 36 |
| 2024 5 | 27 | 5 | 32 |
| 2024 4 | 42 | 14 | 56 |
| 2024 3 | 50 | 7 | 57 |
| 2024 2 | 55 | 11 | 66 |
| 2024 1 | 56 | 10 | 66 |
| 2023 12 | 45 | 6 | 51 |
| 2023 11 | 65 | 12 | 77 |
| 2023 10 | 59 | 18 | 77 |
| 2023 9 | 36 | 9 | 45 |
| 2023 8 | 50 | 9 | 59 |
| 2023 7 | 62 | 18 | 80 |
| 2023 6 | 66 | 9 | 75 |
| 2023 5 | 89 | 7 | 96 |
| 2023 4 | 57 | 5 | 62 |
| 2023 3 | 74 | 8 | 82 |
| 2023 2 | 46 | 4 | 50 |
| 2022 1 | 53 | 3 | 56 |
| 2022 12 | 37 | 5 | 42 |
| 2022 11 | 54 | 6 | 60 |
| 2022 10 | 42 | 10 | 52 |
| 2022 9 | 66 | 18 | 84 |
| 2022 8 | 46 | 18 | 64 |
| 2022 7 | 21 | 7 | 28 |
| 2022 6 | 61 | 7 | 68 |
| 2022 5 | 40 | 10 | 50 |
| 2022 4 | 45 | 10 | 55 |
| 2022 3 | 90 | 10 | 100 |
| 2022 2 | 49 | 23 | 72 |
| 2021 1 | 112 | 19 | 131 |
| 2021 12 | 75 | 8 | 83 |
| 2021 11 | 39 | 12 | 51 |
| 2021 10 | 63 | 15 | 78 |
| 2021 9 | 34 | 20 | 54 |
| 2021 8 | 48 | 10 | 58 |
| 2021 7 | 31 | 13 | 44 |
| 2021 6 | 20 | 12 | 32 |
| 2021 5 | 25 | 18 | 43 |
| 2021 4 | 69 | 5 | 74 |
| 2021 3 | 52 | 26 | 78 |
| 2021 2 | 33 | 13 | 46 |
| 2020 1 | 43 | 15 | 58 |
| 2020 12 | 41 | 11 | 52 |
| 2020 11 | 37 | 7 | 44 |
| 2020 10 | 48 | 11 | 59 |
| 2020 9 | 32 | 9 | 41 |
| 2020 8 | 35 | 12 | 47 |
| 2020 7 | 42 | 8 | 50 |
| 2020 6 | 40 | 20 | 60 |
| 2020 5 | 33 | 19 | 52 |
| 2020 4 | 27 | 11 | 38 |
| 2020 3 | 27 | 20 | 47 |
| 2020 2 | 20 | 13 | 33 |
| 2020 1 | 22 | 12 | 34 |
| 2019 12 | 31 | 5 | 36 |
| 2019 11 | 16 | 13 | 29 |
| 2019 10 | 21 | 5 | 26 |
| 2019 9 | 41 | 5 | 46 |
| 2019 8 | 12 | 14 | 26 |
| 2019 7 | 26 | 19 | 45 |
| 2019 6 | 76 | 8 | 84 |
| 2019 5 | 176 | 45 | 221 |
| 2019 4 | 112 | 45 | 157 |
| 2019 3 | 16 | 2 | 18 |
| 2019 2 | 16 | 9 | 25 |
| 2019 1 | 13 | 7 | 20 |
| 2018 12 | 13 | 13 | 26 |
| 2018 11 | 23 | 10 | 33 |
| 2018 10 | 28 | 17 | 45 |
| 2018 9 | 21 | 6 | 27 |
| 2018 8 | 13 | 4 | 17 |
| 2018 7 | 11 | 2 | 13 |
| 2018 6 | 11 | 2 | 13 |
| 2018 5 | 27 | 8 | 35 |
| 2018 4 | 12 | 5 | 17 |
| 2018 3 | 12 | 2 | 14 |
| 2018 2 | 9 | 4 | 13 |
| 2018 1 | 31 | 3 | 34 |
| 2017 12 | 39 | 3 | 42 |
| 2017 11 | 14 | 11 | 25 |
| 2017 10 | 24 | 7 | 31 |
| 2017 9 | 16 | 8 | 24 |
| 2017 8 | 27 | 3 | 30 |
| 2017 7 | 22 | 2 | 24 |
| 2017 6 | 17 | 11 | 28 |
| 2017 5 | 16 | 15 | 31 |
| 2017 4 | 18 | 1 | 19 |
| 2017 3 | 33 | 16 | 49 |
| 2017 2 | 23 | 8 | 31 |
| 2016 1 | 37 | 3 | 40 |
| 2016 12 | 40 | 13 | 53 |
| 2016 11 | 55 | 11 | 66 |
| 2016 10 | 70 | 17 | 87 |
| 2016 9 | 46 | 6 | 52 |
| 2016 8 | 58 | 11 | 69 |
| 2016 7 | 47 | 16 | 63 |
| 2016 6 | 42 | 22 | 64 |
| 2016 5 | 45 | 39 | 84 |
| 2016 4 | 45 | 39 | 84 |
| 2016 3 | 81 | 50 | 131 |
| 2016 2 | 70 | 36 | 106 |
| 2015 1 | 107 | 47 | 154 |
| 2015 12 | 138 | 68 | 206 |
| 2015 11 | 50 | 39 | 89 |
Mostrar todo
